Follow the Live #NephTrials Discussion on Spironolactone and its Impact on Dialysis Patients
Join the latest #NephTrials discussion on September 28, 2021, at 9 p.m. EST.
The conversation will focus on Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), which evaluates if spironolactone reduces heart failure and heart-related deaths in dialysis patients.
The #NephTrials initiative is an exciting series of conversations combining expertise from the ISN-ACT Global Trials Focus, the ISN-ACT Toolkit, and the #NephJC community.
To access the discussion: Follow @NephJC and @ISNkidneycare, type “NephTrials” in Twitter’s search bar, go to “latest,” and “follow” the conversation #NephTrials #NephJC.
The ISN has designed an easy-to-follow infographic here to help you join the conversation in a few clicks.
